🔎 Trials Near Me

Gara Jalqabaatti › Kansara Harkaa (Karsinomaa Seli Renal) › Connecticut › New Haven

Qorannoo klinikaalii Kansara Harkaa (Karsinomaa Seli Renal) New Haven, CT keessatti

Qorannoo 13 Kansara Harkaa (Karsinomaa Seli Renal) f New Haven fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma

Namoota walitti qabaa jiraSadarkaa 1
  • NEO-811 Connecticut Site, New Haven
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07300241

A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

Namoota walitti qabaa jiraSadarkaa 1
  • Yale - New Haven Hospital, New Haven
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06234605

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • Exelixis Clinical Site #62, New Haven
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT05176483

A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)

Namoota walitti qabaa jiraSadarkaa 1/2
  • Local Institution - 0117, New Haven
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT07293351

Testing the Safety and Feasibility of Immunotherapy Drugs, Botensilimab and Balstilimab, Before Surgery for Clear Cell Renal Cell Carcinoma, NEO RoBOT Trial

Namoota walitti qabaa jiraSadarkaa 2
  • Yale University Cancer Center LAO, New Haven
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT07516366

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

Namoota walitti qabaa jiraSadarkaa 3
  • Yale University, New Haven
  • Smilow Cancer Hospital-Derby Care Center, Derby · Miili 8 fagaatti
  • Smilow Cancer Hospital Care Center - Guilford, Guilford · Miili 13 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Ful-2026 · NCT06661720

Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

Namoota walitti qabaa jiraSadarkaa 1
  • Xencor Investigative Site, New Haven
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 03-Hag-2026 · NCT05433142

A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • Yale University Hospital, New Haven
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ado-2026 · NCT03972657

Investigation of Lymph Node Biology in Kidney Cancer

Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
  • Yale University, New Haven
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Wax-2026 · NCT07038733

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • Yale University School of Medicine /ID# 225707, New Haven
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Wax-2026 · NCT04777994

A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body

Namoota walitti qabaa jiraSadarkaa 1/2
  • Yale School of Medicine, North Haven · Miili 7 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Elb-2026 · NCT06413680

Trial Of Stereotactic Body Radiation Therapy (SBRT) for Oligoprogression on Immune Checkpoint Inhibitors (ICI) in Metastatic Renal Cell Carcinoma

Namoota walitti qabaa jiraSadarkaa 2
  • Yale University, New Haven
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Mud-2025 · NCT04974671

Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067

Namoota walitti qabaa jiraSadarkaa 1/2
  • Yale Cancer Center, New Haven
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Sad-2024 · NCT04787042

Qorannoo Kansara Harkaa (Karsinomaa Seli Renal) magaalota biroo keessatti

Qorannoo biroo New Haven keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.